Driven by a passion to understand the human mind and supported by decades of rigorous inquiry into consciousness studies, CIIS created the Center for Psychedelic Therapies and Research (CPTR) in 2015. This included the first-ever university-affiliated psychedelic therapies and research certificate program, which continues to serve as the gold standard for post-graduate professional training in psychedelics. Psychedelic-assisted therapy is poised to revolutionize clinical mental health treatment, and we are leading the way.
 

Certificate in Psychedelic-Assisted Therapies & Research

Applications for the 2024-2025 cohort are now closed. Please contact us at cptradmissions@ciis.edu with any inquiries.

Explore the Certificate

CIIS' Center for Psychedelic Therapies and Research offers a certificate program where students and teachers engage in an immersive, rigorous curriculum that covers both theoretical foundations and practical applications, including topics such as pharmacology, psychological integration, therapist competencies, historical practices of consciousness transformation, and ethical therapeutic methods. The roots of this certificate are in the work of scholars and researchers on psychedelic-assisted psychotherapies, transpersonal psychology, consciousness studies, psychoanalysis, comparative mysticism, cultural anthropology, and Indigenous plant medicine practices.

CPTR has taken on the vision of bringing the interface of science and the sacred to the world. In the next five years, more and more trained therapists will be released into the world, bringing a new, more awakened way of seeing ourselves and the world we live in. I am deeply grateful to have trained at CPTR, and now deeply honoured to continue to participate in the beautiful vision as a Mentor with CPTR.

- Dr. Dawn DeCunha, C. Psych., Founder & Psychologist at Psychology Works

CIIS’ Psychedelic-Assisted Therapies and Research Certificate Program serves a growing need for the training of skilled therapists and researchers who will ideally seek advanced training for future FDA-approved psychedelic-assisted and entactogen-assisted psychotherapy research and clinical work. As psychedelic-assisted therapies continue to gain recognition for their transformative potential, CPTR’s role as a thought leader will remain essential in ensuring safe, effective, and evidence-based implementation for the benefit of patients worldwide. Moreover, through public policy initiatives, international conferences, and media outreach, our Center continues to contribute to shaping public opinion, supporting a future in which these treatments are widely accessible.